Company Monitoring Page for ASCO

latest headlines for company on cafepharma

Deal struck to mine cancer patient database for new treatment insights
Stat
Thu, 12/21/17 - 10:41 pm
Tags:
patients, cancer, ASCO, CancerLinQ
ASCO spotlight presaged two more biotech IPOs angling for $215M
Endpoints
Tue, 09/5/17 - 09:35 am
Tags:
ASCO, IPOs, biotech, Deciphera, DCC-2618, Nucana, Acelarin
Prepping for ASCO? Investor Brad Loncar offers his own breakdown of what to watch for
Endpoints
Tue, 05/30/17 - 11:48 am
Tags:
ASCO, IDO inhibitors, CAR-T, PDL-1 inhibitors, Merck, Incyte, NewLink Genetics, Novartis, Juno Therapeutics, Bristol-Myers Squibb
AstraZeneca looks to DNA damage-response drugs for edge in oncology
BioPharma Dive
Tue, 05/17/16 - 09:25 am
Tags:
AstraZeneca, oncology, ASCO, Lynparza
Roche Still Waiting For The Big Push
Seeking Alpha
Tue, 04/26/16 - 09:55 am
Tags:
Roche, ASCO, immuno-oncology, Amgen, Merck, Bristol-Myers Squibb
Lilly's Alimta gets rating boost in update to ASCO's drug scorecard
Fierce Pharma
Wed, 07/15/15 - 12:23 pm
Tags:
Eli Lilly, Alimta, ASCO, lung cancer
How 6 ASCO Biotech Winners Are Focusing on the Future of Cancer
24/7 Wall St
Sun, 06/7/15 - 10:07 am
Tags:
biotech, ASCO, Immunogen, Exelixis, Oncothyreon, CTI BioPharma, Immunomedics, Vascular Biogenics
Top-Performing Biotech and Drug Stocks During ASCO '15
TheStreet.com
Fri, 06/5/15 - 07:13 pm
Tags:
ASCO, Ignyta, Immunogen, Puma Biotechnology, AbbVie, Roche, Bristol-Myers Squibb, Seattle Genetics, Juno Therapeutics
Amgen: The Quiet Winner
Barron's
Wed, 06/3/15 - 12:36 pm
Tags:
Amgen, ASCO, Kyprolis
ASCO Wrapup: Immunotherapy Shines, Hope For Brain Tumors, & The Great Cancer Drug Price Debate
Forbes
Wed, 06/3/15 - 11:04 am
Tags:
ASCO, cancer immunotherapy, glioblastoma multiforme, Merck, Genentech, Celldex Therapeutics
16 Biotech Stocks Moving Off The ASCO Conference
Yahoo/Benzinga
Tue, 06/2/15 - 10:06 am
Tags:
biotech, ASCO, Bristol-Myers Squibb, Immunogen, Oncothyreon, Clovis Oncology, CTI BioPharma, Exelixis, Roche, Amgen, AstraZeneca, Puma Biotechnology, Vascular Biogenics, Immunomedics, Momenta, Eli Lilly, Juno Therapeutics, Express Scripts
The 4 Overlooked Winners of ASCO
24/7 Wall St
Tue, 06/2/15 - 09:12 am
Tags:
ASCO, Bristol-Myers Squibb, AbbVie, Aveo Pharmaceuticals, Ignyta
Merck KGaA sees immunotherapy drug holding its own in cancer race
Yahoo/Reuters
Tue, 06/2/15 - 09:06 am
Tags:
Merck KGaA, avelumab, Pfizer, ASCO, cancer immunotherapy
Pfizer's Ibrance Takes Another Giant Leap Forward
Investopedia
Tue, 06/2/15 - 09:03 am
Tags:
Pfizer, Ibrance, ASCO, breast cancer
The Biggest Selling Cancer Drugs In 2020 Show Significant Change Expected In Five Short Years
Forbes
Mon, 06/1/15 - 11:34 pm
Tags:
ASCO, PDL-1 inhibitors, Merck, Bristol-Myers Squibb, Keytruda, Opdivo
ASCO '15 Report Card: Grading Biotech and Drug Stocks at Cancer Drug Confab
TheStreet.com
Mon, 06/1/15 - 11:29 pm
Tags:
ASCO, Oncothyreon, Immunogen, Bristol-Myers Squibb, Merck, Clovis Oncology, Roche, CTI BioPharma, Celldex Therapeutics, Puma Biotechnology, Express Scripts
Pfizer gaining market share in oncology: CEO
CNBC
Mon, 06/1/15 - 07:46 pm
Tags:
Pfizer, oncology, Pharma CEOs, Ian Read, ASCO
At ASCO: Bristol-Myers Rises on More Data About Cancer Drug
Barron's
Mon, 06/1/15 - 07:11 pm
Tags:
ASCO, Bristol-Myers Squibb, Opdivo
ASCO 15: The top 10 setbacks, advances and head scratchers
Fierce Biotech
Mon, 06/1/15 - 12:15 pm
Tags:
ASCO, Celldex Therapeutics, Opdivo, Keytruda, Merck, Bristol-Myers Squibb, Clovis Oncology, AstraZeneca, Genentech
Top Oncologist To Convention Of Doctors, Pharma Execs: New Cancer Treatments Cost Too Much
Forbes
Mon, 06/1/15 - 12:06 pm
Tags:
ASCO, physicians, drug pricing, drug costs

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.